Kreaxi
Overview
Kreaxi is a management specialist for over 25 years in the investment company with capital of startups and technology with great potential. We invest in the first rounds of tables € 100K to € 2.5M to support entrepreneurs in priming, starting and accelerating their startups.
Investment Focus
- Innovative and high-growth potential startups
- Strong founding team
- Sustainable competitive advantages
- Clear growth and exit potential within 5 to 7 years
Portfolio Companies
Reach Kreaxi directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Kreaxi
What sectors does Kreaxi invest in?
Kreaxi invests in Technology, Healthcare, Software, EdTech, FinTech and Life Sciences, and is based in Champagne-Au-Mont-D'or, Rhone-Alpes, France. Kreaxi is listed as a vc in the ConnectSafely investor database.
What stage does Kreaxi invest at?
Kreaxi backs companies at Seed, Early Stage, Series A and Series B, writing cheques of $100K - $500K.
Which regions does Kreaxi invest in?
Kreaxi invests across United Kingdom, Germany, France, Italy, Denmark and Switzerland.
What companies has Kreaxi invested in?
Kreaxi's portfolio includes Erytech Pharma, Sentryo, Docea Power, Amoeba, Mathym, Groupe Terresens, Nanobiotix and PX Therapeutics.
How do I contact Kreaxi?
Kreaxi's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
